Con estrema soddisfazione l'azienda diffonde la presente nota in merito alla completa assoluzione del nostro direttore scientifico, Prof. Roberto Ferrari:
"Al termine di un lungo e sofferto percorso giudiziario, la Corte d’Appello di Milano ha restituito la dignità e la reputazione al Prof. Roberto Ferrari. I Giudici di secondo grado hanno cancellato la condanna inflitta in primo grado dal Tribunale di Pavia per concorso in bancarotta fraudolenta per distrazione ai danni di Fondazione Maugeuri, pronunciando sentenza di assoluzione perché il fatto non sussiste."

Si allega il dispositivo della sentenza:

MTA is a Contract Research Organization (CRO). As an independent organization, MTA supports the identification and development processes of promising therapeutic approaches proposed by research institutes, universities, pharmaceutical, biomedical and tech-med companies offering support in the product’s development and quality certified assessment of new medical strategies in the clinical setting.

MTA is more than a CRO because it represents an academic-rooted organisation supporting medical products development ensuring planning, management and coordination of clinical studies and clinical services at certified international quality standards.

Because your project is unique! Our mission is to provide tailored services aimed to FOCUS, harmonize the entire trial management process and to SPEED the INNOVATION in MEDICAL SCIENCE toward the delivery of any new therapeutic treatment or intervention that will improve patient quality of life.